Presentation
13 March 2024 Synergistic photodynamic therapy and ethanol ablation of locally advanced tumors in vivo
Author Affiliations +
Abstract
Hepatocellular carcinoma (HCC) is the second most common cause of cancer deaths worldwide, with 800,000 deaths per year. Since surgical options for HCC patients are limited, minimally invasive ablative therapies are critical to treat early-stage HCC; however, their cost and need for specialized equipment and expertise prevent widespread use in underprivileged populations. Here, we propose a lower-cost Light-Activatable, Sustained-exposure Ethanol Injection Technology (LASEIT) to augment current options for underprivileged patients.
Conference Presentation
© (2024) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Chen-Hua Ma, Jeffrey Yang, John Quinlan, Kathryn McNaughton, Tessa Hauser, Jenna Mueller, and Huang-Chiao Huang "Synergistic photodynamic therapy and ethanol ablation of locally advanced tumors in vivo", Proc. SPIE PC12823, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXXII, PC128230F (13 March 2024); https://doi.org/10.1117/12.3011919
Advertisement
Advertisement
KEYWORDS
Ablation

Bioalcohols

Photodynamic therapy

Tumors

In vivo imaging

Tissues

Liver

Back to Top